Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines.

Silber JH, Cnaan A, Clark BJ, Paridon SM, Chin AJ, Rychik J, Hogarty AN, Cohen MI, Barber G, Rutkowski M, Kimball TR, Delaat C, Steinherz LJ, Zhao H.

J Clin Oncol. 2004 Mar 1;22(5):820-8.

PMID:
14990637
2.

Design and baseline characteristics for the ACE Inhibitor After Anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors.

Silber JH, Cnaan A, Clark BJ, Paridon SM, Chin AJ, Rychik J, Hogarty AN, Cohen MI, Barber G, Rutkowsky M, Kimball TR, Delaat C, Steinherz LJ, Zhao H, Tartaglione MR.

Am Heart J. 2001 Oct;142(4):577-85.

PMID:
11579345
3.

Using health-related quality of life measures to predict cardiac function in survivors exposed to anthracyclines.

Ginsberg JP, Cnaan A, Zhao H, Clark BJ, Paridon SM, Chin AJ, Rychik J, Hogarty AN, Barber G, Rutkowski M, Kimball TR, DeLaat C, Steinherz LJ, Silber JH.

J Clin Oncol. 2004 Aug 1;22(15):3149-55.

PMID:
15284267
4.

Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.

Cheuk DK, Sieswerda E, van Dalen EC, Postma A, Kremer LC.

Cochrane Database Syst Rev. 2016 Aug 23;(8):CD008011. doi: 10.1002/14651858.CD008011.pub3. Review.

PMID:
27552363
5.
6.

Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.

Sieswerda E, van Dalen EC, Postma A, Cheuk DK, Caron HN, Kremer LC.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD008011. doi: 10.1002/14651858.CD008011.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;8:CD008011.

PMID:
21901716
7.
8.

Exposure to anthracyclines during childhood causes cardiac injury.

Lipshultz SE.

Semin Oncol. 2006 Jun;33(3 Suppl 8):S8-14. Review.

PMID:
16781284
9.

[The effects of enalapril on exercise capacity and right ventricular function in patients with chronic cor pulmonale].

Pérez-Calvo J, Civeira F, Ferrando J, Martínez-Rodés P, Torralba MA, Banzo J, Prats E, Bueno J.

An Med Interna. 2000 Oct;17(10):527-32. Spanish.

PMID:
11109647
10.
11.
12.

The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.

Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z; Amlodipine Versus Enalapril in Renal failure (AVER) Study Group..

Clin Ther. 2008 Mar;30(3):482-98. doi: 10.1016/j.clinthera.2008.03.006.

PMID:
18405787
13.

[Effectiveness of long-term ACE-inhibition on pulmonary diffusion and ventilation-perfusion ratio in chronic heart failure: correlation with physical performance].

Guazzi M, Pontone G, Trevisi N, Lomanto M, Melzi G, Agostoni P.

Ann Ital Med Int. 1998 Jan-Mar;13(1):17-23. Italian.

PMID:
9642838
14.

Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.

Sharpe DN, Murphy J, Coxon R, Hannan SF.

Circulation. 1984 Aug;70(2):271-8.

PMID:
6329547
15.

Enalapril does not enhance exercise capacity in patients after Fontan procedure.

Kouatli AA, Garcia JA, Zellers TM, Weinstein EM, Mahony L.

Circulation. 1997 Sep 2;96(5):1507-12.

17.
18.

Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure.

Creager MA, Massie BM, Faxon DP, Friedman SD, Kramer BL, Weiner DA, Ryan TJ, Topic N, Melidossian CD.

J Am Coll Cardiol. 1985 Jul;6(1):163-73.

PMID:
2989349
19.
20.

Tolerance to ACE inhibitors after cardiac surgery.

Manché A, Galea J, Busuttil W.

Eur J Cardiothorac Surg. 1999 Jan;15(1):55-60.

PMID:
10077374

Supplemental Content

Support Center